These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29789395)

  • 1. Blood Pressure-Attained Analysis of ATACH 2 Trial.
    Qureshi AI; Palesch YY; Foster LD; Barsan WG; Goldstein JN; Hanley DF; Hsu CY; Moy CS; Qureshi MH; Silbergleit R; Suarez JI; Toyoda K; Yamamoto H;
    Stroke; 2018 Jun; 49(6):1412-1418. PubMed ID: 29789395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
    Tanaka K; Koga M; Fukuda-Doi M; Qureshi AI; Yamamoto H; Miwa K; Ihara M; Toyoda K;
    Stroke; 2022 Jun; 53(6):1854-1862. PubMed ID: 35400202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.
    Qureshi AI; Huang W; Lobanova I; Barsan WG; Hanley DF; Hsu CY; Lin CL; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Yamamoto H;
    JAMA Neurol; 2020 Nov; 77(11):1355-1365. PubMed ID: 32897310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
    Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
    Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
    Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
    Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
    Qureshi AI; Palesch YY; Barsan WG; Hanley DF; Hsu CY; Martin RL; Moy CS; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Wang Y; Yamamoto H; Yoon BW;
    N Engl J Med; 2016 Sep; 375(11):1033-43. PubMed ID: 27276234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results.
    Carcel C; Wang X; Sato S; Stapf C; Sandset EC; Delcourt C; Arima H; Robinson T; Lavados P; Chalmers J; Anderson CS;
    Stroke; 2016 Jun; 47(6):1651-3. PubMed ID: 27143274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.
    Qureshi AI; Palesch YY
    Neurocrit Care; 2011 Dec; 15(3):559-76. PubMed ID: 21626077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-intracerebral hemorrhage study.
    Tanaka E; Koga M; Kobayashi J; Kario K; Kamiyama K; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Todo K; Kimura K; Okada Y; Okata T; Arihiro S; Sato S; Yamagami H; Nagatsuka K; Minematsu K; Toyoda K
    Stroke; 2014 Aug; 45(8):2275-9. PubMed ID: 24968929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2.
    Fukuda-Doi M; Yamamoto H; Koga M; Palesch YY; Durkalski-Mauldin VL; Qureshi AI; Yoshimura S; Okazaki S; Miwa K; Okada Y; Ueda T; Okuda S; Nakahara J; Suzuki N; Toyoda K
    Stroke; 2020 Aug; 51(8):2282-2286. PubMed ID: 32623977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.
    Qureshi AI; Palesch YY; Martin R; Novitzke J; Cruz-Flores S; Ehtisham A; Ezzeddine MA; Goldstein JN; Hussein HM; Suri MF; Tariq N;
    Arch Neurol; 2010 May; 67(5):570-6. PubMed ID: 20457956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.
    Wang X; Arima H; Yang J; Zhang S; Wu G; Woodward M; Muñoz-Venturelli P; Lavados PM; Stapf C; Robinson T; Heeley E; Delcourt C; Lindley RI; Parsons M; Chalmers J; Anderson CS;
    Stroke; 2015 Oct; 46(10):2762-7. PubMed ID: 26265125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network].
    Sato S; Yamamoto H; Qureshi AI; Palesch YY; Toyoda K;
    Rinsho Shinkeigaku; 2012; 52(9):642-50. PubMed ID: 22989898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage.
    Moullaali TJ; Wang X; Martin RH; Shipes VB; Qureshi AI; Anderson CS; Palesch YY
    Int J Stroke; 2019 Apr; 14(3):321-328. PubMed ID: 30418098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study.
    Sakamoto Y; Koga M; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Arihiro S; Sato S; Kobayashi J; Tanaka E; Nagatsuka K; Minematsu K; Toyoda K;
    Stroke; 2013 Jul; 44(7):1846-51. PubMed ID: 23704107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage.
    Toyoda K; Koga M; Yamamoto H; Foster L; Palesch YY; Wang Y; Sakai N; Hara T; Hsu CY; Itabashi R; Sato S; Fukuda-Doi M; Steiner T; Yoon BW; Hanley DF; Qureshi AI;
    Ann Neurol; 2019 Jan; 85(1):105-113. PubMed ID: 30421455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Renal Impairment on Intensive Blood-Pressure-Lowering Therapy and Outcomes in Intracerebral Hemorrhage: Results From ATACH-2.
    Fukuda-Doi M; Yamamoto H; Koga M; Doi Y; Qureshi AI; Yoshimura S; Miwa K; Ishigami A; Shiozawa M; Omae K; Ihara M; Toyoda K
    Neurology; 2021 Aug; 97(9):e913-e921. PubMed ID: 34210824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2.
    Arima H; Heeley E; Delcourt C; Hirakawa Y; Wang X; Woodward M; Robinson T; Stapf C; Parsons M; Lavados PM; Huang Y; Wang J; Chalmers J; Anderson CS; ;
    Neurology; 2015 Feb; 84(5):464-71. PubMed ID: 25552575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Blood Pressure Lowering and DWI Lesions in Intracerebral Hemorrhage: Exploratory Analysis of the ATACH-2 Randomized Trial.
    Shoamanesh A; Cassarly C; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel M; Butcher K; Gioia L; Ayres A; Vashkevich A; Schwab K; Afzal MR; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    Neurocrit Care; 2022 Feb; 36(1):71-81. PubMed ID: 34292474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
    Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.